We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.48B
AUM Growth
-$64.4M
(-4.2%)
Cap. Flow
-$213M
Cap. Flow
% of AUM
-14.38%
Top 10 Holdings %
Top 10 Hldgs %
48.42%
Holding
44
New
6
Increased
5
Reduced
16
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$54M |
| 2 |
SHPG
Shire pic
SHPG
|
+$49.4M |
| 3 |
Armstrong World Industries
AWI
|
+$43.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.6M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$72.1M |
| 2 |
Labcorp
LH
|
+$57.3M |
| 3 |
AET
Aetna Inc
AET
|
+$28.5M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$27.8M |
| 5 |
Centene
CNC
|
+$25.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.69% |
| 2 | Consumer Discretionary | 10.31% |
| 3 | Communication Services | 9.2% |
| 4 | Industrials | 8.19% |
| 5 | Consumer Staples | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
MGM Resorts International
MGM
$11.4B
| $103M | 6.94% |
3,958,970
| – | – |
|
2
Biogen
BIIB
$30.2B
| $79.5M | 5.36% |
254,050
+33,551
| +15% | +$9.94M |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $79.2M | 5.34% |
2,098,000
-314,501
| -13% | -$11.9M |
|
|
WMGI
4
DELISTED
Wright Medical Group Inc
WMGI
| $78.3M | 5.27% |
3,190,076
-789,765
| -20% | -$18.2M |
|
5
Post Holdings
POST
$4.17B
| $78.1M | 5.27% |
1,547,236
-152,800
| -9% | -$8.38M |
|
|
6
Alnylam Pharmaceuticals
ALNY
$27.3B
| $66.6M | 4.49% |
983,040
+296,031
| +43% | +$20.9M |
|
7
Teva Pharmaceuticals
TEVA
$40.6B
| $62.5M | 4.21% |
1,358,287
+53,715
| +4% | +$2.8M |
|
|
8
Ironwood Pharmaceuticals
IRWD
$680M
| $62.3M | 4.2% |
4,685,654
-2,380,036
| -34% | -$27.8M |
|
|
9
Humana
HUM
$44.6B
| $55.1M | 3.71% |
+311,235
| New | +$54M |
|
10
Meta Platforms (Facebook)
META
$1.39T
| $54M | 3.64% |
420,598
| – | – |
|
11
Charter Communications
CHTR
$17.3B
| $52M | 3.5% |
192,448
-37,056
| -16% | -$9.36M |
|
|
SHPG
12
DELISTED
Shire pic
SHPG
| $49.1M | 3.31% |
+253,419
| New | +$49.4M |
|
13
Nektar Therapeutics
NKTR
$2.37B
| $48.7M | 3.28% |
188,842
-51,062
| -21% | -$13.1M |
|
14
DexCom
DXCM
$31.9B
| $47.2M | 3.18% |
2,155,436
-678,144
| -24% | -$15.1M |
|
15
Pacific Biosciences
PACB
$438M
| $44.5M | 3% |
4,964,123
-218,116
| -4% | -$1.82M |
|
|
16
Armstrong World Industries
AWI
$7.31B
| $42.8M | 2.88% |
+1,034,642
| New | +$43.3M |
|
|
KSU
17
DELISTED
Kansas City Southern
KSU
| $42M | 2.83% |
449,703
| – | – |
|
18
TG Therapeutics
TGTX
$8.01B
| $40.3M | 2.71% |
5,204,618
| – | – |
|
|
GRUB
19
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $36.8M | 2.48% |
428,018
-325,582
| -43% | -$24.4M |
|
20
Liberty Broadband Class A
LBRDA
$4.87B
| $30.6M | 2.06% |
435,892
| – | – |
|
|
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
| $27.7M | 1.86% |
236,292
-137,851
| -37% | -$15.4M |
|
|
22
Labcorp
LH
$25.2B
| $26.9M | 1.81% |
227,966
-486,595
| -68% | -$57.3M |
|
|
23
Gilead Sciences
GILD
$162B
| $26.9M | 1.81% |
+339,451
| New | +$27.6M |
|
|
AET
24
DELISTED
Aetna Inc
AET
| $26.5M | 1.79% |
229,683
-243,416
| -51% | -$28.5M |
|
|
25
Centene
CNC
$30.6B
| $26.2M | 1.76% |
782,030
-738,360
| -49% | -$25.6M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q3 2016 Portfolio in Review
As of Q3 2016, Bridger Management held 44 positions worth $1.48B, down 4.2% from $1.55B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Bridger Management withdrew a net $213M in Q3 2016, closing 7 positions and reducing 16 holdings. Its most notable exit was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $72.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 53% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Bridger Management opened a new position in Humana worth $55.1M.
- Bridger Management's largest Q3 2016 buy was Humana: 311,235 shares worth $55.1M.
- Bridger Management added most to Alnylam Pharmaceuticals in Q3 2016, an estimated $20.9M increase.
- Bridger Management's biggest Q3 2016 reduction was Labcorp, cutting an estimated $57.3M.
- Bridger Management fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2016, selling an estimated $72.1M.
- Bridger Management's ten largest holdings make up 48% of its $1.48B portfolio in Q3 2016.
- Bridger Management opened 6 new positions and closed 7 in Q3 2016.
- Bridger Management's portfolio value fell 4.2% quarter-over-quarter to $1.48B.
Based on Bridger Management's 13F filing for Q3 2016, filed 14 Nov 2016.